Generic Name and Formulations:
Tetrahydrozoline HCl 0.1%; nasal soln; contains benzalkonium chloride.
Indications for TYZINE:
Adults and Children:
<6yrs: see Contraindications. ≥6yrs: 2–4 drops in each nostril as needed; max: every 3hrs.
Children <6yrs. Concomitant MAO inhibitors.
Do not exceed recommended doses. Cardiovascular disease. Hyperthyroidism. Diabetes. Discontinue if adverse reactions occur. Children. Pregnancy (Cat.C). Nursing mothers.
Hypertensive crisis with MAOIs.
Local effects (eg, burning, stinging, sneezing, dryness of the mucosa), headaches, drowsiness, weakness, tremors, lightheadedness, insomnia, palpitations, rebound congestion.
Soln—15mL (w. dropper)
Clinical Pain Advisor Articles
- Two Screening Tools May Accurately Predict Transition From Acute to Chronic Low Back Pain
- Predicting the Magnitude of Placebo Analgesia in Chronic Pain
- Operant Learning May Provide More Benefits Than Energy Conservation in Fibromyalgia
- Methamphetamine Use on the Rise in Patients With Opioid Use Disorder
- Tools to Address the Opioid Crisis
- The Unintended Consequences of the CDC Opioid Guideline According to Pain Management Specialists
- Initial Consultation for Neck Pain May Reduce Opioid Consumption, Healthcare Utilization
- FDA-Approved Test Provides Pharmacogenetic Reports Directly to Consumers
- Set of Interventions May Effectively Reduce Opioid Overprescribing
- Cannabinoid-Associated Analgesia May Be Mediated Through Modulation of Affective Processes
- Nonsinogenic Headache vs Chronic Rhinosinusitis Differential Diagnosis Based on SNOT-22 Patterns
- Patterns of Non-Medical Prescription Opioid Use in Adolescents
- Factors Promoting Participation in Self-Management Training Program for Chronic Pain
- Gendered Perceptions of Socially Acceptable Pain Relief Strategies
- Majority of Internists Still Have Financial Ties to Industry